NFKBIA and lung carcinoma: Interestingly, this analysis showed a profile very similar to the one previously identified in primary samples, with NFKBIA predominantly amplified in lung cancer, deleted in kidney and variously expressed in breast, large intestine and hematological tumors (Fig. S1B).